Senzime AB (publ) (SNZZF) Financials

SNZZF Assets vs Liabilities

DateAssetsLiabilities
March 31, 2026 36.6 million 6.9 million
Dec. 31, 2025 40.1 million 7.1 million
Sept. 30, 2025 43.4 million 6.7 million
June 30, 2025 46.0 million 6.8 million

SNZZF Free Cash Flow and Stock based compensation

No data available :(

SNZZF Net Income

No data available :(

SNZZF Cash and Debt

Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 5.8 million 783478 1.5 million
Dec. 31, 2025 8.0 million 1.3 million 1.3 million
Sept. 30, 2025 11.2 million - 1.4 million
June 30, 2025 14.0 million - 1.6 million

SNZZF Shares Outstanding

No data available :(

SNZZF Expenses

Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 292289 591996 3.2 million 2.2 million
Dec. 31, 2025 21775 641560 3.8 million -
Sept. 30, 2025 106169 708577 3.1 million -
June 30, 2025 524673 614586 3.7 million 2.5 million

SNZZF Cost of Revenue

Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 2.4 million 1.4 million
Dec. 31, 2025 3.1 million 2.9 million
Sept. 30, 2025 2.8 million 1.7 million
June 30, 2025 2.7 million 1.6 million

SNZZF

Price: $0.48

52 week price:
0.45
0.74

Earnings Per Share: -0.10 USD

P/E Ratio: -5.35

Exchange: OQX

Sector: Healthcare

Industry: Medical Devices

Market Capitalization: 75.2 million

Links: